Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
about
Mycobacterium tuberculosis Thioredoxin Reductase Is Essential for Thiol Redox Homeostasis but Plays a Minor Role in Antioxidant DefenseRepurposing clinically approved cephalosporins for tuberculosis therapyRifabutin Is Active against Mycobacterium abscessus Complex.Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem.Non-classical transpeptidases yield insight into new antibacterialsClinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems.Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.NTM drug discovery: status, gaps and the way forward.Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.A Simple and Rapid Gene Disruption Strategy in Mycobacterium abscessus: On the Design and Application of Glycopeptidolipid Mutants.Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.Teicoplanin - Tigecycline Combination Shows Synergy Against Mycobacterium abscessus.Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Futureand β-Lactams: Emerging Insights and Potential OpportunitiesTedizolid Activity Against Clinical Complex Isolates-An Characterization Study
P2860
Q28552573-BC5CE10D-4B3D-459E-9822-285438519101Q28828720-C2689580-D325-465C-AA3C-41B036E975A1Q33726686-12307816-3276-46BD-B2A9-146959B25608Q33730985-09BE57EA-E85F-405C-B806-5D3296C0C5FBQ33814192-8FB8BF9B-EEDF-45BD-B04D-9AC87A4927DCQ36099490-350A7A8D-C600-4CA7-AB6D-123803F10BF4Q36355735-E13BE0F3-506D-4E5C-9F4A-A62EDBC2A1E1Q37339290-12ED52A6-CDD4-400B-B82E-307B46090D59Q38677546-BD16C220-8BF0-49EF-8AFA-CB64EC1CABC3Q38741819-CC1F55D3-8F4D-4F2F-8B2D-C2752FF43DD4Q38969052-48FD190B-5557-496B-9B42-E3D267D23657Q39030679-C1E160E0-0752-4DA9-A06F-C25C8EEAF154Q40187337-89C1BE93-B1B5-472C-909F-C039BAA651C5Q41293939-21081875-F9A9-4B25-B02B-3A9312B5C7C3Q41864236-ED423863-6284-4E74-86EE-81EE31076525Q46594059-9AF26AEB-7EB8-4904-BF8E-7577D6A26CFCQ47429675-E47A0A82-43AA-41B8-B955-00E882867545Q47687876-2202C084-A7FA-482A-AACF-672558587377Q48318081-BB7C1952-2C08-43EC-9C25-45D0EA1CCB13Q52596288-E573A554-36F7-48DD-A67E-3F828BF61189Q52684515-C178EA98-1F50-4DA3-BD60-67E4A06B990AQ52690344-F7268E05-B3CB-4C89-B5A1-6B02B5C5B2BAQ53408541-9EB555B2-822C-45B1-B948-7CD3A2CDA183Q55381713-96F9B514-A981-47E5-824B-EDAA95FEF48BQ57158690-C0677F45-925B-41F6-809E-7092E764954BQ57492057-DF5D0A41-7AE1-4495-AA5B-D71C10061D69Q58758954-600EDFF0-3460-4C08-85AE-DB6971375DFD
P2860
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@ast
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@en
type
label
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@ast
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@en
prefLabel
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@ast
Carbapenems and Rifampin Exhib ...... s and Mycobacterium abscessus.
@en
P2093
P2860
P356
P1476
Carbapenems and Rifampin Exhib ...... is and Mycobacterium abscessus
@en
P2093
Amit Kaushik
Nayani Makkar
Nicole Parrish
Pooja Pandey
Urvashi Singh
P2860
P304
P356
10.1128/AAC.01158-15
P407
P577
2015-08-10T00:00:00Z